跳至主要内容
临床试验/NCT04166253
NCT04166253已完成2 期

The Potential Protective Effects of Vitamin (D) Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Damanhour University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Troponin-T in ng/l

研究概览

简要总结

The study is aimed at Evaluation of the potential protective effect of Vitamin D in doxorubucin- induced toxicity in breast cancer patients.

Proposal Steps:

  1. 100 Patients recruited from Alexandria Main University Hospital (AMUH), Oncology Unit are randomly assigned in to two groups:
  • Control group (n=50) the patient will receive AC regimen (Doxorubucin & cyclophosphamide) for 4 cycles every 21 day (i.e. 3 months.)
  • Vitamin D group (n=50) who will receive 4 Cycles AC regimen in addition to vitamin D (Bon One 0.5 microgram®) once daily.
  1. Echocardiography (Echo) will be done at base line and at the end of the treatment.
  2. Vitamin D, LDH, Troponin-t as well as IL-6 will be assessed at baseline and at the end of the study.

详细描述

Research Objectives: Evaluation of the potential protective effect of Vitamin D in doxorubucin- induced toxicity in breast cancer patients.

Proposal Steps:

  1. Assessing breast cancer patients taking part in the study receiving adjuvant chemotherapy AC (Anthracycline (Doxorubucin)-cyclophosphamide) for breast cancer for 4 cycles every 21 day (i.e. 3 months.)
  2. 100 Patients are randomly assigned in to two groups:
  • Control group (n=50) the patient will receive AC regimen (Doxorubucin & Cyclophosphamide) for 4 cycles every 21 day (i.e. 3 months.)
  • Vitamin D group (n=50) who will receive 4 Cycles AC regimen in addition to vitamin D once daily.
  1. All participants are recruited from AMUH Hospital Oncology Unit. All participants will be given their consent. The study will be approved by research ethics committee of Damanhour University.
  2. Tumor staging is done according to American joint committee on cancer (TNM staging of breast cancer eighth edition (Amin et al., 2017).
  3. All patients will be submitted to:
  • Full patient history and clinical examination.
  • Routine follow up before and after each chemotherapy cycle (complete blood picture, liver function tests, renal function tests.
  1. Echocardiography (Echo) at base line and at the end of the treatment.
  2. Vitamin D, LDH, Troponin-t as well as IL-6 will be assessed at baseline and at the end of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

盲法说明

The participant did not know the exact drug he is using.

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients has a good performance status (ECOG 0-2) according to eastern cooperative oncology group (ECOG) score.
  • Adequate complete blood picture patients.
  • Females from (30-65) years of old.
  • Normal renal and liver functions.
  • Exclusion criteria:
  • Cardiac diseased or reduced cardiac output with left ventricular ejection fraction less than 50%.
  • Hepatic impaired patients.
  • Pregnancy or breast feeding or child bearing state.
  • Patient with history of allergy to vitamin D.
  • Concomitant use of other vitamins.
  • Renal impaired patients.
  • History of breast cancer.

排除标准

  • 未提供

研究组 & 干预措施

Vitamin D group

Experimental

Intervention group of breast cancer patients will receive adjuvant AC chemotherapy in addition to vitamin D (alfacalcidol 0.5 mcg orally once daily

干预措施: Vitamin D (Drug)

结局指标

主要结局

Troponin-T in ng/l

时间窗: 3 months

A change in plasma levels of Troponin-T in ng/l

Interleukin-6 in MIU/ml

时间窗: 3 months

A change in plasma levels of Interleukin-6 in MIU/ ml

Vitamin D in ng/ml

时间窗: 3 months

A change in plasma levels of Vitamin D in ng / ml

LDH in U/L

时间窗: 3 months

A change in plasma levels of LDH in U/L

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Noha El Bassiouny

Lecturer of clinical pharmacy

Damanhour University

研究点 (1)

Loading locations...

相似试验

Protective Role of Vitamin D in Breast Cancer... | 临床试验